CD56 marks human dendritic cell subsets with cytotoxic potential. - Wikidata - wikimedia - TriplyDB

CD56 marks human dendritic cell subsets with cytotoxic potential.

CD56 marks human dendritic cell subsets with cytotoxic potential.

http://www.wikidata.org/entity/Q42269630

about

HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner.The Prognostic Impact of NK/NKT Cell Density in Periampullary Adenocarcinoma Differs by Morphological Type and Adjuvant Treatment Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells Interferon α may be back on track to treat acute myeloid leukemia.Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy.Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy.CD56 in the Immune System: More Than a Marker for Cytotoxicity?Trial watch: Dendritic cell-based interventions for cancer therapy.GFRA1: A Novel Molecular Target for the Prevention of Osteosarcoma Chemoresistance.

P2860

Q34011491-8420BEA4-DE44-474D-8CEE-2CFCBFC0236F Q35624376-5747E546-0C8C-4031-A584-C2A37ABC87BC Q36044748-A92A9B6E-E610-4F55-929A-313C3CF64AFB Q37294760-38EFDA26-71D0-4E1E-BFBE-3E1138969373 Q38111770-40265E77-94DC-4BFE-A9BF-2419494DCFA6 Q38115438-97A5C209-8743-41DE-B4E0-D0275EF04EC1 Q38206571-596BF8E0-CBF0-49C0-AD79-E9E8839C37F8 Q40101148-DBCD00D7-6E70-4F57-A8B7-C2A47A127554 Q42867339-6C09FC3D-0BF8-449A-8B51-1C3D6BF7EC8B Q52607614-31AC6495-80DE-4768-9D38-F07A82244A80

P2860

CD56 marks human dendritic cell subsets with cytotoxic potential.

http://www.wikidata.org/entity/Q42269630

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

CD56 marks human dendritic cell subsets with cytotoxic potential.

@en

CD56 marks human dendritic cell subsets with cytotoxic potential.

@nl

type

label

CD56 marks human dendritic cell subsets with cytotoxic potential.

@en

CD56 marks human dendritic cell subsets with cytotoxic potential.

@nl

prefLabel

CD56 marks human dendritic cell subsets with cytotoxic potential.

@en

CD56 marks human dendritic cell subsets with cytotoxic potential.

@nl

P1433

Q42269630-83CF3F04-21F8-40FD-BEC5-74E9BA0D7F21

P1476

Q42269630-A7781031-6F3E-4110-8015-5E2E9085AE8C

P2093

Q42269630-1E92D597-6882-4DE3-8764-D0CEF3C3313F

Q42269630-7FE398BA-83DA-4ACB-AEBE-E60EC9F52723

Q42269630-8A1AB343-0925-429A-BD53-81589E429F58

Q42269630-C7DB60AE-9661-4B5E-8A54-917B6D3AE6C8

P2860

Q42269630-1F9A3515-A2CC-4D82-B6EC-B3040E0303E7

Q42269630-6EE3B843-A404-4095-9CAD-ECB056147BEB

Q42269630-8DF23B29-0323-4834-8F74-8E8CE8126631

Q42269630-8E674B7B-4FAD-4742-9C83-7FD6F93FB276

Q42269630-BF4EF7E4-A103-425A-9971-1C0CF5BA22D5

Q42269630-EAAE142D-3561-4AF8-88BC-AD741EC60783

Q42269630-EF6BC34D-5738-4FA3-8582-CECD6A941AED

Q42269630-FFE5EE57-DBEE-4EE9-BD99-99DA63ABB8A6

P304

Q42269630-2BBE5EF0-2FBD-43D3-BE2E-B91E53D3B73C

P31

Q42269630-79B3F9FB-8940-44AE-84BB-A1A198D1A5D8

P356

Q42269630-428717AB-E258-412A-920C-017993F7E487

P433

Q42269630-E1B276DA-965C-4A8B-9B4D-5EDBAE4BCAC6

P478

Q42269630-0E84C383-8FBE-4C8F-9F1B-75C1D190CEFA

P50

Q42269630-B7D77BDB-542F-4F9B-9BEC-CD2ED5759BE6

P577

Q42269630-4E0FF53F-82FD-4E99-B9CF-FC689B7E4A76

P5875

Q42269630-F5116DFB-079F-403A-8872-2A098E8EF38E

P698

Q42269630-0988736F-014D-46D3-8A9B-A89EC964C147

P932

Q42269630-0D654BC0-1CD4-4D8C-B902-5120B82C91C1

P356

P1433

P1476

CD56 marks human dendritic cell subsets with cytotoxic potential.

@en

P2093

Dessie Roothans

http://www.w3.org/2001/XMLSchema#string

Eva Lion

http://www.w3.org/2001/XMLSchema#string

Evelien Smits

http://www.w3.org/2001/XMLSchema#string

Sébastien Anguille

http://www.w3.org/2001/XMLSchema#string

P2860

BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood

Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential.

A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis.

Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4.

Killer dendritic cells and their potential for cancer immunotherapy.

Dendritic cell vaccination in acute myeloid leukemia.

Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities.

Involvement of CD56 (NKH-1/Leu-19 antigen) as an adhesion molecule in natural killer-target cell interaction.

P304

e23037

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/ONCI.23037

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236076252

http://www.w3.org/2001/XMLSchema#string

P698

23524451

http://www.w3.org/2001/XMLSchema#string

P932

3601173

http://www.w3.org/2001/XMLSchema#string